<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">akusherstvo</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics, Gynecology and Reproduction</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство, Гинекология и Репродукция</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7347</issn><issn pub-type="epub">2500-3194</issn><publisher><publisher-name>IRBIS LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.17749/2313-7347/ob.gyn.rep.2023.409</article-id><article-id custom-type="elpub" pub-id-type="custom">akusherstvo-1786</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ОRIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group></article-categories><title-group><article-title>Chemotranscriptomic analysis of 7-hydroxymatairesinol-related effects on MCF7 human breast tumor cells</article-title><trans-title-group xml:lang="ru"><trans-title>Хемотранскриптомный анализ эффектов молекулы 7-гидроксиматаирезинола на опухолевые клетки молочной железы человека линии MCF7</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2659-7998</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Торшин</surname><given-names>И. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Torshin</surname><given-names>I. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Торшин Иван Юрьевич – к.ф-м.н., к.х.н., старший научный сотрудник</p><p>Scopus Author ID: 7003300274</p><p>Author ID: 54104</p><p>WOS ID: C-7683-2018</p><p>119333 Москва, ул. Вавилова, д. 44</p></bio><bio xml:lang="en"><p>Ivan Yu. Torshin – PhD in Applied Mathematics, PhD in Chemistry, Senior Researcher</p><p>Scopus Author ID: 7003300274</p><p>Author ID: 54104</p><p>WOS ID: C-7683-2018</p><p>44 Vavilova Str., Moscow 119333</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9639-2525</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рубашкина</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Rubashkina</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рубашкина Анна Николаевна – аспирант кафедры онкологии, акушерства и гинекологии</p><p>153012 Иваново, Шереметевский проспект, д. 8</p></bio><bio xml:lang="en"><p>Anna N. Rubashkina – MD, Postgraduate Student, Department of Oncology, Obstetrics and Gynecology</p><p>8 Sheremetevsky Prospect, Ivanovo 153012</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7663-710X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Громова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gromova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Громова Ольга Алексеевна – д.м.н., профессор, ведущий научный сотрудник</p><p>119333 Москва, ул. Вавилова, д. 44</p></bio><bio xml:lang="en"><p>Olga A. Gromova – MD, Dr Sci Med, Professor, Leading Researcher</p><p>44 Vavilova Str., Moscow 119333</p></bio><email xlink:type="simple">unesco.gromova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГУ Федеральный исследовательский центр «Информатика и управление» Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Federal Research Center "Computer Science and Control", Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ивановская государственная медицинская академия» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ivanovo State Medical Academy, Health Ministry of Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>21</day><month>09</month><year>2023</year></pub-date><volume>17</volume><issue>5</issue><fpage>584</fpage><lpage>596</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Torshin I.Y., Rubashkina A.N., Gromova O.A., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Торшин И.Ю., Рубашкина А.Н., Громова О.А.</copyright-holder><copyright-holder xml:lang="en">Torshin I.Y., Rubashkina A.N., Gromova O.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gynecology.su/jour/article/view/1786">https://www.gynecology.su/jour/article/view/1786</self-uri><abstract><sec><title>Introduction</title><p>Introduction. Establishing the effects of anticancer drugs on the transcriptome is an important procedure in postgenomic pharmacology necessary to comprehensively assess the desired and undesirable effects of candidate drugs. </p></sec><sec><title>Aim</title><p>Aim: to assess the effects of lignan 7-hydroxymatairesinol (7HMR) on breast tumor cells.</p></sec><sec><title>Materials and Methods</title><p>Materials and Methods. Chemotranscriptome profiling was carried out in MCF7 cells (breast cancer cell line) after 24-hour incubation with 7HMR. The GEO (Gene Expression Omnibus) database contains samples of data from transcriptomic studies allowing to model dose-dependent compound-related effects on gene expression based on the chemograph-derived combinatorial analysis algorithms. As a result, a panel of genes with altered expression is generated, which are analyzed by the functional linkage method using the international nomenclature of Gene Ontology (GO) linked to biological roles of genes/proteins.</p></sec><sec><title>Results</title><p>Results. Dose-dependent effects of 7HMR on gene transcription (change in transcription by 5 % or more per 1 μmol 7HMR) were established for 3,468 out of 12,700 genes studied. 7HMR significantly reduced the expression of genes involved in maintaining cell proliferation (401 genes including those involved in telomere maintenance), protein synthesis (194 genes) and proteasomal protein degradation (70 genes), energy metabolism in tumor cells (91 genes) and chronic inflammation (148 genes). A decline in the expression of such gene groups retards the processes of proliferation and vital activity along with protecting host body from excessive inflammation. 7HMR contributed to a predominant increase in the transcription of gene groups involved in antitumor activity (more than 100 genes), including the genes involved in maintaining antitumor immunity as well as those mediating the antitumor effects of vitamin D, retinoids, and vitamin C.</p></sec><sec><title>Conclusion</title><p>Conclusion. The revealed changes in gene transcription enhance 7HMR-related effects on proteome proteins and suggest the prospects for using 7HMR for effective and safe prevention and treatment of nodular mastopathy and breast cancer.</p></sec></abstract><trans-abstract xml:lang="ru"><sec><title>Введение</title><p>Введение. Установление эффектов воздействия онкопротекторных средств на транскриптом – важная процедура фармакологии, необходимая для комплексной оценки желательных и нежелательных свойств препаратов-кандидатов.</p></sec><sec><title>Цель</title><p>Цель: оценка транскриптомных эффектов лигнана 7-гидроксиматаирезинола (7ГМР) по отношению к клеткам опухоли молочной железы.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Хемотранскриптомный анализ 7ГМР проведен для клеток линии MCF7 (опухолевые клетки рака молочной железы) в условиях инкубации с клетками в течение 24 ч. В базе данных GEO (англ. Gene Expression Omnibus) находятся выборки данных транскриптомных исследований, и на основании алгоритмов комбинаторного анализа хемографов моделируется дозозависимое воздействие молекулы на экспрессию генов. В результате формируются списки генов с изменённой экспрессией, которые анализируются методом функционального связывания с использованием международной номенклатуры Gene Ontology (GO) по биологическим ролям генов/белков.</p></sec><sec><title>Результаты</title><p>Результаты. Установлены дозозависимые эффекты воздействия 7ГМР на транскрипцию генов (изменение транскрипции на 5 % или более на 1 мкмоль 7ГМР) для 3468 из 12700 исследованных генов: 7ГМР достоверно снижал экспрессию генов, вовлечённых в поддержание пролиферации клеток (401 гена, в том числе генов, участвующих в поддержании теломер), синтез белка (194 генов) и протеасомную деградацию белков (70 генов), энергетический метаболизм опухолевых клеток (91 гена) и хроническое воспаление (148 генов). Уменьшение экспрессии этих групп генов тормозит процессы пролиферации и жизнедеятельности, одновременно защищая организм от избыточного воспаления. 7ГМР способствовал преимущественному повышению транскрипции групп генов, вовлеченных в онкопротекторное действие (более 100 генов), в том числе генов, участвующих в поддержании онкопротекторного иммунитета, а также генов, опосредующих онкопротекторные свойства витамина D, ретиноидов и витамина С.</p></sec><sec><title>Заключение</title><p>Заключение. Выявленные изменения в транскрипции генов усиливают воздействие 7ГМР на белки протеома и указывают на перспективы использования 7ГМР для эффективной и безопасной профилактики и терапии узловой мастопатии и рака молочной железы.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хемотранскриптомика</kwd><kwd>7-гидроксиматаирезинол</kwd><kwd>7ГМР</kwd><kwd>интеллектуальный анализ данных</kwd><kwd>молекулярная фармакология</kwd><kwd>Лигнариус</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chemotranscriptomics</kwd><kwd>7-hydroxymatairesinol</kwd><kwd>7HMR</kwd><kwd>data mining</kwd><kwd>molecular pharmacology</kwd><kwd>Lignarius</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена при поддержке гранта РНФ (проект № 23-21-00154).</funding-statement><funding-statement xml:lang="en">The study was financially supported by the Russian Science Foundation (Project No. 23-21-00154).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Рубашкина А.Н. и др. Систематический анализ фундаментальных и клинических исследований лигнана 7-гидроксиматаирезинола. Эффективная фармакотерапия. 2019;15(13):34–41. https://doi.org/10.33978/2307-3586-201915-13-34-41.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Rubashkina A.N. et al. Systematic analysis of fundamental and clinical studies of lignan 7-hydroxymatairesinol. [Sistematicheskij analiz fundamental'nyh i klinicheskih issledovanij lignana 7-gidroksimatairezinola]. Effektivnaya farmakoterapiya. 2019;15(13):34–41. (In Russ.). https://doi.org/10.33978/2307-3586-2019-15-13-34-41.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Рубашкина А.Н., Лапочкина Н.П., Громова О.А. Хемореактомный анализ 7-гидроксиматаирезинола, 17-эстрадиола, фитоэстрогена β-ситостирола и эпигаллокатехин-3галлата. Акушерство, Гинекология и Репродукция. 2020;14(3):347–60. https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.152.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Rubashkina A.N., Lapochkina N.P., Gromova O.A. Chemoreactome analysis of 7hydroxymatairesinol, 17-estradiol, phytoestrogen β-sitosterol and epigallocatechin-3-gallate. [Hemoreaktomnyj analiz 7-gidroksimatairezinola, 17-estradiola, fitoestrogena β-sitostirola i epigallokatekhin-3-gallata]. Obstetrics, Gynecology and Reproduction. 2020;14(3):347–60. (In Russ.). https://doi.org/10.17749/2313-7347/ob.gyn.rep.2020.152.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Рубашкина А.Н., Лапочкина Н.П., Торшин И.Ю., Громова О.А. Роль 7гидроксиматаирезинола в модуляции метаболизма эстрогенов и терапии мастопатии. Гинекология. 2020;22(4):43–8. https://doi.org/10.26442/20795696.2020.4.200183.</mixed-citation><mixed-citation xml:lang="en">Rubashkina A.N., Lapochkina N.P., Torshin I.Y., Gromova O.A. The role of 7-hydroxymatairezinol in modulation of estrogen metabolism and therapy for mastopathy. [Rol' 7-gidroksimatairezinola v modulyacii metabolizma estrogenov i terapii mastopatii]. Ginekologiya. 2020;22(4):43–8. (In Russ.). https://doi.org/10.26442/20795696.2020.4.200183.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin I.Yu. Sensing the change from molecular genetics to personalized medicine. In: "Bioinformatics in the Post-Genomic Era" series. NY, USA: Nova Biomedical Books, 2009. 366 p. ISBN 1-60692-217-0.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu. Sensing the change from molecular genetics to personalized medicine. In: "Bioinformatics in the Post-Genomic Era" series. NY, USA: Nova Biomedical Books, 2009. 366 p. ISBN 1-60692-217-0.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А. Экспертный анализ данных в молекулярной фармакологии. М., 2012. 684 с.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Gromova O.A. Expert data analysis in molecular pharmacology. [Ekspertnyj analiz dannyh v molekulyarnoj farmakologii]. Moscow, 2012. 684 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А., Фролова Д.Е. и др. Дозозависимый хемотранскриптомный анализ дифференциального действия витамина D на экспрессию генов в клетках-предшественниках нейронов NPC и в опухолевых клетках MCF7 человека. Фармакокинетика и фармакодинамика. 2018;(2):35–51. https://doi.org/10.24411/2587-78362018-10013.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Gromova O.A., Frolova D.E. et al. Dose-dependent chemotranscriptomics analysis of the differential effects of vitamin D3 on gene expression in human neuronal progenitor cells NPC and in MCF7 tumor cells. [Dozozavisimyj hemotranskriptomnyj analiz differencial'nogo dejstviya vitamina D na ekspressiyu genov v kletkah-predshestvennikah nejronov NPC i v opuholevyh kletkah MCF7 cheloveka]. Farmakokinetika i farmakodinamika. 2018;(2):35–51. (In Russ).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin I. Yu., Rudakov K.V. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2014;24(1):11–23. https://doi.org/10.1134/S1054661814010209.</mixed-citation><mixed-citation xml:lang="en">Torshin I. Yu., Rudakov K.V. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 1: fundamentals of modern chemical bonding theory and the concept of the chemograph. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2014;24(1):11–23. https://doi.org/10.1134/S1054661814010209.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Торшин И.Ю., Громова О.А., Федотова Л.Э. и др. Хемоинформационный анализ молекулы оротовой кислоты указывает на противовоспалительные, нейропротекторные и кардиопротекторные эффекта лиганда магния. Фарматека. 2013;(13): 95–104.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Yu., Gromova O.A., Fedotova L.E. et al. Chemoinformatic analysis of orotic acid molecule indicates anti-inflammatory, neuroprotective and cardioprotective effects of magnesium ligand. [Hemoinformacionnyj analiz molekuly orotovoj kisloty ukazyvaet na protivovospalitel'nye, nejroprotektornye i kardioprotektornye effekta liganda magniya]. Farmateka. 2013;(13): 95–104. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Федотова Л.Э., Громов А.Н. Хемореактомный анализ сукцината этилметилгидроксипиридина. Неврология, нейропсихиатрия, психосоматика. 2016;8(3):53–60. https://doi.org/10.14412/2074-2711-2016-3-53-60.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Fedotova L.E., Gromov A.N. Chemoreactome analysis of ethylmethylhydroxypyridine succinate. Neurology, neuropsychiatry, psychosomatics. [Hemoreaktomnyj analiz sukcinata etilmetilgidroksipiridina]. Nevrologiya, nejropsihiatriya, psihosomatika. 2016;8(3):53–60. (In Russ.). https://doi.org/10.14412/2074-2711-2016-3-53-60.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Федотова Л.Э. Геронтоинформационный анализ эффект молекулы мексидола. Неврология, нейропсихиатрия, психосоматика. 2017;9(4):46–54. https://doi.org/10.14412/2074-2711-2017-4-46-54.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Fedotova L.E. Geriatric information analysis of the molecular properties of mexidole. [Gerontoinformacionnyj analiz effekt molekuly meksidola]. Nevrologiya, nejropsihiatriya, psihosomatika. 2017;9(4):46–54. (In Russ.). https://doi.org/10.14412/2074-27112017-4-46-54.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin I.Y. The study of the solvability of the genome annotation problem on sets of elementary motifs. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2011;21(4):652–62. https://doi.org/10.1134/S1054661811040171.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Y. The study of the solvability of the genome annotation problem on sets of elementary motifs. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2011;21(4):652–62. https://doi.org/10.1134/S1054661811040171.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin I.Y., Rudakov K.V. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 1: factorization approach. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2017;27(1):16–28. https://doi.org/10.1134/S1054661817010151.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Y., Rudakov K.V. Combinatorial analysis of the solvability properties of the problems of recognition and completeness of algorithmic models. Part 1: factorization approach. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2017;27(1):16–28. https://doi.org/10.1134/S1054661817010151.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Torshin I.Y., Rudakov K.V. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 2: local completeness of invariants of chemographs in view of the combinatorial theory of solvability. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2014;24(2):196–208. https://doi.org/10.1134/S1054661814020151.</mixed-citation><mixed-citation xml:lang="en">Torshin I.Y., Rudakov K.V. On the application of the combinatorial theory of solvability to the analysis of chemographs. Part 2: local completeness of invariants of chemographs in view of the combinatorial theory of solvability. Pattern Recognition and Image Analysis. Advances in Mathematical Theory and Applications. 2014;24(2):196–208. https://doi.org/10.1134/S1054661814020151.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mouchemore K.A., Anderson R.L., Hamilton J.A. Neutrophils, G-CSF and their contribution to breast cancer metastasis. FEBS J. 2018;285(4):665–79. https://doi.org/10.1111/febs.14206.</mixed-citation><mixed-citation xml:lang="en">Mouchemore K.A., Anderson R.L., Hamilton J.A. Neutrophils, G-CSF and their contribution to breast cancer metastasis. FEBS J. 2018;285(4):665–79. https://doi.org/10.1111/febs.14206.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Mohammed Z.M., Going J.J., Edwards J. et al. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer. 2012;107(5):864–73. https://doi.org/10.1038/bjc.2012.347.</mixed-citation><mixed-citation xml:lang="en">Mohammed Z.M., Going J.J., Edwards J. et al. The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer. 2012;107(5):864–73. https://doi.org/10.1038/bjc.2012.347.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y., Yu X., Song H. et al. The STAT-ROS cycle extends IFN-induced cancer cell apoptosis. Int J Oncol. 2018;52(1):305–13. https://doi.org/10.3892/ijo.2017.4196.</mixed-citation><mixed-citation xml:lang="en">Wang Y., Yu X., Song H. et al. The STAT-ROS cycle extends IFN-induced cancer cell apoptosis. Int J Oncol. 2018;52(1):305–13. https://doi.org/10.3892/ijo.2017.4196.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Li J., Zhang J., Jin L. et al. Silencing lnc-ASAH2B-2 inhibits breast cancer cell growth via the mTOR pathway. Anticancer Res. 2018;38(6):3427–34. https://doi.org/10.21873/anticanres.</mixed-citation><mixed-citation xml:lang="en">Li J., Zhang J., Jin L. et al. Silencing lnc-ASAH2B-2 inhibits breast cancer cell growth via the mTOR pathway. Anticancer Res. 2018;38(6):3427–34. https://doi.org/10.21873/anticanres.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Rogowski M., Gollahon L., Chellini G., Assadi-Porter F.M. Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells. FEBS Open Bio. 2017;7(4):587– 601. https://doi.org/10.1002/2211-5463.12205.</mixed-citation><mixed-citation xml:lang="en">Rogowski M., Gollahon L., Chellini G., Assadi-Porter F.M. Uptake of 3-iodothyronamine hormone analogs inhibits the growth and viability of cancer cells. FEBS Open Bio. 2017;7(4):587– 601. https://doi.org/10.1002/2211-5463.12205.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Furbert-Harris P.M., Laniyan I., Harris D. et al. Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids. Anticancer Res. 2003;23(1A):71–8.</mixed-citation><mixed-citation xml:lang="en">Furbert-Harris P.M., Laniyan I., Harris D. et al. Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids. Anticancer Res. 2003;23(1A):71–8.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю. Витамин D. Смена парадигмы. Под ред. Е.И. Гусева, И.Н. Захаровой. М.: ГЭОТАР-Медиа, 2017. 568 с.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu. Vitamin D. Paradigm change. [Vitamin D. Smena paradigmy. Pod red. E.I. Guseva, I.N. Zaharovoj]. Moscow: GEOTAR-Media, 2017. 568 p. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Aouad P., Saikali M., Abdel-Samad R. et al. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models. Anticancer Drugs. 2017;28(7):757–70. https://doi.org/10.1097/CAD.0000000000000511.</mixed-citation><mixed-citation xml:lang="en">Aouad P., Saikali M., Abdel-Samad R. et al. Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models. Anticancer Drugs. 2017;28(7):757–70. https://doi.org/10.1097/CAD.0000000000000511.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Филимонова М.В., Сорокина М.А. Роль витаминов в профилактике рака и их влияние на эффективность онкопротекторной терапии: систематический анализ доказательных исследований. Терапия. 2018;(4):108–20.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Filimonova M.V., Sorokina M.A. The role of vitamins in cancer prevention and their influence at anticancer treatment efficacy: systematic analysis of evidentiary research works. [Rol' vitaminov v profilaktike raka i ih vliyanie na effektivnost' onkoprotektornoj terapii: sistematicheskij analiz dokazatel'nyh issledovanij. Terapiya. 2018;(4):108–20. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Громова О.А., Торшин И.Ю., Мартынов А.И. и др. Систематический анализ применения витаминов в рамках многопрофильного стационара. Терапия. 2017;(6):89–99.</mixed-citation><mixed-citation xml:lang="en">Gromova O.A., Torshin I.Yu., Martynov A.I. et al. Systematic analysis of vitamins use in a multidisciplinary hospital. [Sistematicheskij analiz primeneniya vitaminov v ramkah mnogoprofil'nogo stacionara]]. Terapiya. 2017;(6):89–99. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wang M., Cheng D., Peng J., Pickart C.M. Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase. EMBO J. 2006;25(8):1710–19. https://doi.org/10.1038/sj.emboj.7601061.</mixed-citation><mixed-citation xml:lang="en">Wang M., Cheng D., Peng J., Pickart C.M. Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase. EMBO J. 2006;25(8):1710–19. https://doi.org/10.1038/sj.emboj.7601061.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Grieb B.C., Gramling M.W., Arrate M.P. et al. Oncogenic protein MTBP interacts with MYC to promote tumorigenesis. Cancer Res. 2014;74(13):3591–602. https://doi.org/10.1158/00085472.CAN-13-2149.</mixed-citation><mixed-citation xml:lang="en">Grieb B.C., Gramling M.W., Arrate M.P. et al. Oncogenic protein MTBP interacts with MYC to promote tumorigenesis. Cancer Res. 2014;74(13):3591–602. https://doi.org/10.1158/00085472.CAN-13-2149.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41(1):181–90. https://doi.org/10.1016/0022-5193(73)90198-7.</mixed-citation><mixed-citation xml:lang="en">Olovnikov A.M. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973;41(1):181–90. https://doi.org/10.1016/0022-5193(73)90198-7.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Heiss N.S., Bachner D., Salowsky R. et al. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1. Genomics. 2000;67(2):153–63. https://doi.org/10.1006/geno.2000.6227.</mixed-citation><mixed-citation xml:lang="en">Heiss N.S., Bachner D., Salowsky R. et al. Gene structure and expression of the mouse dyskeratosis congenita gene, dkc1. Genomics. 2000;67(2):153–63. https://doi.org/10.1006/geno.2000.6227.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Ye J., Lenain C., Bauwens S. et al. TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell. 2010;142(2):230–42. https://doi.org/10.1016/j.cell.2010.05.032.</mixed-citation><mixed-citation xml:lang="en">Ye J., Lenain C., Bauwens S. et al. TRF2 and apollo cooperate with topoisomerase 2alpha to protect human telomeres from replicative damage. Cell. 2010;142(2):230–42. https://doi.org/10.1016/j.cell.2010.05.032.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Wang C., Meier U.T. Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins. EMBO J. 2004;23(8):1857–67. https://doi.org/10.1038/sj.emboj.7600181.</mixed-citation><mixed-citation xml:lang="en">Wang C., Meier U.T. Architecture and assembly of mammalian H/ACA small nucleolar and telomerase ribonucleoproteins. EMBO J. 2004;23(8):1857–67. https://doi.org/10.1038/sj.emboj.7600181.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Jafri M.A., Ansari S.A., Alqahtani M.H., Shay J.W. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med. 2016;8(1):69. https://doi.org/10.1186/s13073-016-0324-x.</mixed-citation><mixed-citation xml:lang="en">Jafri M.A., Ansari S.A., Alqahtani M.H., Shay J.W. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med. 2016;8(1):69. https://doi.org/10.1186/s13073-016-0324-x.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Favre B., Plantard L., Aeschbach L. et al. SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda. J Invest Dermatol. 2007;127(2):301–8. https://doi.org/10.1038/sj.jid.5700551.</mixed-citation><mixed-citation xml:lang="en">Favre B., Plantard L., Aeschbach L. et al. SLURP1 is a late marker of epidermal differentiation and is absent in Mal de Meleda. J Invest Dermatol. 2007;127(2):301–8. https://doi.org/10.1038/sj.jid.5700551.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ridge R.J., Sloane N.H. Partial N-terminal amino acid sequence of the anti-neoplastic urinary protein (ANUP) and the anti-tumour effect of the N-terminal nonapeptide of the unique cytokine present in human granulocytes. Cytokine. 1996;8(1):1–5. https://doi.org/10.1006/cyto.1996.0001.</mixed-citation><mixed-citation xml:lang="en">Ridge R.J., Sloane N.H. Partial N-terminal amino acid sequence of the anti-neoplastic urinary protein (ANUP) and the anti-tumour effect of the N-terminal nonapeptide of the unique cytokine present in human granulocytes. Cytokine. 1996;8(1):1–5. https://doi.org/10.1006/cyto.1996.0001.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Duncan C.J., Mohamad S.M., Young D.F. et al Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci Transl Med. 2015;7(307):307ra154. https://doi.org/10.1126/scitranslmed.aac4227.</mixed-citation><mixed-citation xml:lang="en">Duncan C.J., Mohamad S.M., Young D.F. et al Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci Transl Med. 2015;7(307):307ra154. https://doi.org/10.1126/scitranslmed.aac4227.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Wolfson R.L., Chantranupong L., Wyant G.A. et al. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature. 2017;543(7645):438–42. https://doi.org/10.1038/nature21423.</mixed-citation><mixed-citation xml:lang="en">Wolfson R.L., Chantranupong L., Wyant G.A. et al. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature. 2017;543(7645):438–42. https://doi.org/10.1038/nature21423.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Peng M., Yin N., Li M.O. SZT2 dictates GATOR control of mTORC1 signalling. Nature. 2017;543(7645):433–7. https://doi.org/10.1038/nature21378.</mixed-citation><mixed-citation xml:lang="en">Peng M., Yin N., Li M.O. SZT2 dictates GATOR control of mTORC1 signalling. Nature. 2017;543(7645):433–7. https://doi.org/10.1038/nature21378.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
